Form 8-K - Current report:
SEC Accession No. 0001104659-25-066520
Filing Date
2025-07-09
Accepted
2025-07-08 19:53:26
Documents
14
Period of Report
2025-07-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2520081d1_8k.htm   iXBRL 8-K 25671
2 EXHIBIT 99.1 tm2520081d1_ex99-1.htm EX-99.1 15157
6 GRAPHIC tm2520081d1_ex99-1img001.jpg GRAPHIC 8947
  Complete submission text file 0001104659-25-066520.txt   222439

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbio-20250707.xsd EX-101.SCH 3020
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20250707_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20250707_pre.xml EX-101.PRE 22362
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2520081d1_8k_htm.xml XML 3563
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 251112013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)